Waltz Health is thrilled to announce that we have successfully raised $17.5 million in our latest funding round, a significant boost that will propel our mission to revolutionize prescription care. As a trailblazer in the pharmaceutical supply chain, we are committed to addressing the pressing issues of high costs and poorly designed user experiences that plague the industry today. With a seasoned team of industry experts at the helm, Waltz is leveraging cutting-edge AI technology to develop innovative marketplaces that not only lower medication costs but also enhance the overall consumer experience. This new influx of capital will be instrumental in refining our AI-driven tools designed for payers, pharmacies, and consumers alike. By providing better pricing options, more accessible information, and smarter decision-making resources, we aim to empower individuals to take charge of their healthcare choices. Our vision is to create a seamless, transparent ecosystem where all stakeholders collaborate effectively, leading to improved outcomes for everyone involved. This funding marks a pivotal moment in our journey and will allow us to accelerate the development of our solutions, expand our market presence, and ultimately redefine prescription care for the better. We are excited about the journey ahead and grateful for the support of our investors who believe in our mission to transform healthcare affordability and accessibility. Together, we can make a meaningful impact on the way patients and providers navigate their prescription journeys, ensuring that high-quality care is available to all.








